PT90019A - Processo para a preparacao e purificacao de factor de choque termico humano - Google Patents

Processo para a preparacao e purificacao de factor de choque termico humano

Info

Publication number
PT90019A
PT90019A PT90019A PT9001989A PT90019A PT 90019 A PT90019 A PT 90019A PT 90019 A PT90019 A PT 90019A PT 9001989 A PT9001989 A PT 9001989A PT 90019 A PT90019 A PT 90019A
Authority
PT
Portugal
Prior art keywords
purification
preparation
shock factor
thermal shock
human thermal
Prior art date
Application number
PT90019A
Other languages
English (en)
Other versions
PT90019B (pt
Inventor
Robert E Kingston
Thomas J Schuetz
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/301,417 external-priority patent/US5137805A/en
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of PT90019A publication Critical patent/PT90019A/pt
Publication of PT90019B publication Critical patent/PT90019B/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
PT90019A 1988-03-18 1989-03-16 Processo para a preparacao e purificacao de factor de choque termico humano PT90019B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16996588A 1988-03-18 1988-03-18
US07/301,417 US5137805A (en) 1988-03-18 1989-01-25 Method of diagnosing stress condition by specific binding of human heat shock factor

Publications (2)

Publication Number Publication Date
PT90019A true PT90019A (pt) 1990-11-20
PT90019B PT90019B (pt) 1994-11-30

Family

ID=26865545

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90019A PT90019B (pt) 1988-03-18 1989-03-16 Processo para a preparacao e purificacao de factor de choque termico humano

Country Status (11)

Country Link
EP (1) EP0333201B1 (pt)
JP (1) JPH03503410A (pt)
AT (1) ATE112168T1 (pt)
AU (1) AU645243B2 (pt)
DE (1) DE68918479T2 (pt)
DK (1) DK224790A (pt)
ES (1) ES2064375T3 (pt)
FI (1) FI904564A0 (pt)
IE (1) IE62447B1 (pt)
PT (1) PT90019B (pt)
WO (1) WO1989008661A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009617A1 (en) * 1990-11-26 1992-06-11 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Cell stress transcriptional factors
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
GB9402857D0 (en) * 1994-02-15 1994-04-06 Isis Innovation Targeting gene therapy
WO1999002989A1 (en) * 1997-07-10 1999-01-21 Medical Research Council Chaperone fragments
WO1999016903A1 (fr) * 1997-09-29 1999-04-08 Hsp Research Institute, Inc. Procede de criblage des regulateurs de l'induction de l'expression de proteines de choc thermique
WO2009155936A1 (en) 2008-06-26 2009-12-30 Orphazyme Aps Use of hsp70 as a regulator of enzymatic activity
KR102254140B1 (ko) 2016-04-29 2021-05-24 오르파짐 에이/에스 글루코세레브로시다제 연관 장애를 치료하기 위한 아리모클로몰
IL303026A (en) 2020-11-19 2023-07-01 Zevra Denmark As Processes for preparing arimoclomol citrate and its intermediates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603106A (en) * 1982-02-22 1986-07-29 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
WO1986003007A1 (en) * 1984-11-16 1986-05-22 Chou Iih Nan Assay for the detection of epigenetic toxic substances

Also Published As

Publication number Publication date
ATE112168T1 (de) 1994-10-15
DK224790A (da) 1990-11-15
PT90019B (pt) 1994-11-30
EP0333201B1 (en) 1994-09-28
JPH03503410A (ja) 1991-08-01
DE68918479D1 (de) 1994-11-03
DE68918479T2 (de) 1995-03-02
AU3280489A (en) 1989-10-05
FI904564A0 (fi) 1990-09-17
IE62447B1 (en) 1995-02-08
WO1989008661A1 (en) 1989-09-21
AU645243B2 (en) 1994-01-13
DK224790D0 (da) 1990-09-18
EP0333201A3 (en) 1990-05-09
IE890817L (en) 1989-09-18
EP0333201A2 (en) 1989-09-20
ES2064375T3 (es) 1995-02-01

Similar Documents

Publication Publication Date Title
FI870113A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5,6-substioitujenN-(substituoitu-fenyyli)-2-pyrimidiiniamiinien valmistamiseksi
FI884806A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen tetraliinien, kromaanien ja niitä läheisesti muistuttavien yhdisteiden valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita
NO873822L (no) Framgangsmaate for tilvirkning av keramiske kompositter.
ES2022115B3 (es) Procedimiento de produccion de polimeros que contienen amida alcoxilados/modificados cationicamente
PT90019A (pt) Processo para a preparacao e purificacao de factor de choque termico humano
BR8701887A (pt) Corpo refratario ignitado ligado por carbono,processo para producao de corpo refratario e corpo refratario
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ES537205A0 (es) Procedimiento para preparar derivados de purina
ES553377A0 (es) Procedimiento para la produccion de 2,4,6-tris-(amino-fenilamino)-triacinas
NO873824L (no) Framgangsmaate for tilvirkning av keramiske kompositter.
BR8906227A (pt) Processo para preparar benzeno 3,4-difluoro substituido
PT89667A (pt) Processo para a modificacao de um crivo molecular
IT8548746A0 (it) Procedimento per la produzione di pezzi stampati leggeri refrattari o termoresistenti
DK450086D0 (da) 12- og 13-bromergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
BR8807069A (pt) Material ceramico e processo para preparacao do mesmo
MX163461B (es) Procedimiento para preparar diazaoxaespirodecanos oligomeros,y su utilizacion como agentes fotoprotectores para polimeros
IT8720436A0 (it) Processo per la preparazione del 2,4-diammino-6-(1-piperidinil)-piri mi-din-n-ossido.
DE3878506D1 (de) Hochtemperaturentschweflung von synthesegas.
ES2082890T3 (es) Procedimiento para la preparacion de derivados 6-(aminopropionilo sustituido) de forskolina.
IT1230866B (it) Procedimento per la produzione di coke.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
DK0381114T3 (da) Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
IT8819919A0 (it) Procedimento perfezionato per laproduzione di componenti ceramici.
IT1235649B (it) Processo per la preparazione del 2-metossi-6-propionil-naftalene per acilazione del 2-metossi-naftalene

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940524

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19971130

NF3A Restitutio in integrum

Effective date: 19980401

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19991130